Publication
A quantitative treatment assessment for optimizing combined virotherapy-chemotherapy regimens against HPV-induced cervical cancer.
Salil Ghosh, Amit Kumar Bag, Satyajit Mukherjee, Xianbing Cao, Amarnath Chatterjee, Priti Kumar Roy
PloS oneJan 1, 2026PMID 42766698doi:10.1371/journal.pone.0342672 PMC13592723Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260926-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Cervical cancer is strongly associated with persistent infection by high-risk human papillomavirus (HPV) and continues to pose a major global health burden in recent times. Oncolytic virotherapy has emerged as a promising targeted strategy that selectively eliminates cancer cells while…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Cervical Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.